FDA Inspection 1171244 — Truvape, Inc.
The FDA completed an inspection of Truvape, Inc. on May 19, 2022 in Las Vegas, NV. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Tobacco.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 19, 2022
- Fiscal Year
- 2022
- Product Type
- Tobacco
- Project Area
- Tobacco Post-Market Activities
- Location
- Las Vegas, NV (United States)